knee osteoarthritis. Unspecified osteoarthritis, unspecified site
Conditions
Interventions
Intervention 1: Intervention group: 1, Treatment in group 1 includes taking 15 mg of meloxicam orally daily for ten days and patients will be taught the method of correcting the way of life and Omepra
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: completing and signing a consent form having symptoms of knee osteoarthritis in at least one recent month age between 40 and 60 lack of the presence of any other disease around the affected limb
Exclusion criteria
Exclusion criteria: having diabetes having diseases such as Rheumatism, gout, collagen vascular and lupus having accompanying radiculopathy history of trauma, fracture and injury to the affected joint, nerve damage and neuropathies history of knee replacement on the affected side history of allergies to drugs used in the study history of significant heart, kidney, liver and lung disorders pregnant and lactating women BMI above 42 having brucellosis history of injection in the affected joint or in addition in the last 3 months inability to communicating and completing questionnaires patients taking anticoagulants cancer patients history or gastrointestinal disorders and stomach problems consuming warfarin and ticlopidine and aspirin uncontrolled hypertension very severe osteoarthritis of the knee based on radiology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain rate based on the score obtained from the Visual Analog Scale questionnaire in the study. Timepoint: before and after starting treatment in second , forth and fifth weeks. Method of measurement: Filling in the questionnaire VAS by the patient and reading the questionnaire information.;Knee disability based on the score obtained from the Oxford knee Scale in the study. Timepoint: before and after starting treatment in second , forth and fifth weeks. Method of measurement: Filling in the questionnaire OKS by the patient and reading the questionnaire information.;Morning stiffness based on the score obtained from the Western Ontario and McMaster Universities Arthritis Index in the study. Timepoint: before and after starting treatment in second , forth and fifth weeks. Method of measurement: Filling in the questionnaire WOMAC by the patient and reading the questionnaire information. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Reza Karimi
Shiraz University of Medical Sciences
Outcome results
None listed